MID-VOLUME · HOSP-HEAVY
rivastigmine Side Effects
rivastigmine (also sold as Exelon) sits MID-VOLUME #248 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 36.4% mention hospitalization (6,537 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 17,976
- FAERS reports
FDA Adverse Event Reporting System extract for rivastigmine. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
rivastigmine: 36.4% mention hospitalization (6,537 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #248 of 524 by FAERS report count.
Mid-book FAERS page for rivastigmine (Exelon) (17,976 reports). Signature HOSP-HEAVY. Dominant age band on file: 75+. Educational reference only.
Counts from the openFDA FAERS extract (2000–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
DEATH leads 2,177 of 17,976 reports
Who reports · age peak 75+ (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 75+ (7,025 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (4,544 reports, 25.3%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 2,177 |
| PNEUMONIA | 348 |
| FALL | 238 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 183 |
| PARKINSON^S DISEASE | 178 |
| CEREBROVASCULAR ACCIDENT | 165 |
| CARDIAC ARREST | 164 |
| HALLUCINATION | 141 |
| DEMENTIA | 136 |
| DYSPHAGIA | 134 |
| CARDIO-RESPIRATORY ARREST | 127 |
| URINARY TRACT INFECTION | 127 |
| ASTHENIA | 114 |
| CONDITION AGGRAVATED | 114 |
| MYOCARDIAL INFARCTION | 113 |
| CONFUSIONAL STATE | 110 |
| RESPIRATORY FAILURE | 109 |
| SEPSIS | 103 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (6,537, 36.4% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| FALL | 1,004 |
| CONFUSIONAL STATE | 554 |
| PNEUMONIA | 475 |
| HALLUCINATION | 457 |
| URINARY TRACT INFECTION | 435 |
| VOMITING | 426 |
| NAUSEA | 339 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 324 |
| ASTHENIA | 320 |
| DIARRHOEA | 294 |
| MALAISE | 293 |
| DEHYDRATION | 283 |
| GAIT DISTURBANCE | 282 |
| DIZZINESS | 274 |
| WEIGHT DECREASED | 270 |
| DEATH | 269 |
| FATIGUE | 264 |
| AGITATION | 263 |
| AGGRESSION | 259 |
| SOMNOLENCE | 258 |
How to read rivastigmine FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 17,976 voluntary reports linked to rivastigmine (Exelon), 2000-2025. Death is listed on 4,544 (25.3%). Hospitalization appears on 6,537 (36.4%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 36.4% mention hospitalization (6,537 reports).
Read with rivastigmine
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 17,969 FAERS cases (Δ 7 lighter vs rivastigmine); DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 18,056 FAERS cases (Δ 80 heavier vs rivastigmine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 18,159 FAERS cases (Δ 183 heavier vs rivastigmine); DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 17,740 FAERS cases (Δ 236 lighter vs rivastigmine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 36.8 pp vs rivastigmine's DEATH-HEAVY): CASELOAD · HOSP-MID.
rivastigmine stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.